Anthony Howell, Howell A, Howell T
Anthony Howell, Howell A, Howell T
Professor of Medical Oncology, Manchester University
Verified email at picr.man.ac.uk
Title
Cited by
Cited by
Year
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials
Early Breast Cancer Trialists' Collaborative Group
The Lancet 365 (9472), 1687-1717, 2005
59632005
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials.
M Clarke, R Collins, S Darby, C Davies, P Elphinstone, E Evans, ...
Lancet 366 (9503), 2087, 2005
49322005
Tamoxifen for early breast cancer: an overview of the randomised trials
Early Breast Cancer Trialists' Collaborative Group
The Lancet 351 (9114), 1451-1467, 1998
33301998
Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomised trials involving 31 000 recurrences and 24 000 deaths among 75 000 women
EARLY BREAST CANCER TRIALISTS'COLLABORATIVE GROUP
The Lancet 339 (8784), 1-15, 1992
2587*1992
Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 …
S Darby, P McGale, C Correa, C Taylor, R Arriagada, M Clarke, D Cutter, ...
Lancet 378 (9804), 1707, 2011
23592011
Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years’ adjuvant treatment for breast cancer
A Howell, J Cuzick, M Baum, A Buzdar, M Dowsett, JF Forbes, ...
Lancet 365 (9453), 60-62, 2005
23192005
Polychemotherapy for early breast cancer: an overview of the randomised trials
Early Breast Cancer Trialists' Collaborative Group
The Lancet 352 (9132), 930-942, 1998
18491998
Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC …
A Howell, J Cuzick, M Baum, A Buzdar, M Dowsett, JF Forbes, ...
Lancet 359, 2131-2139, 2005
16132005
Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials.
R Peto, C Davies, J Godwin, R Gray, HC Pan, M Clarke, D Cutter, S Darby, ...
Lancet 379 (9814), 432, 2012
13842012
Adjuvant docetaxel for node-positive breast cancer
M Martin, T Pienkowski, J Mackey, M Pawlicki, JP Guastalla, C Weaver, ...
New England Journal of Medicine 352 (22), 2302-2313, 2005
12182005
Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma: a phase III, double-blind …
LS Rosen, D Gordon, M Kaminski, A Howell, A Belch, J Mackey, ...
Cancer journal (Sudbury, Mass.) 7 (5), 377, 2001
10902001
Long‐term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or …
LS Rosen, D Gordon, M Kaminski, A Howell, A Belch, J Mackey, ...
Cancer: Interdisciplinary International Journal of the American Cancer …, 2003
9802003
Effects of radiotherapy and surgery in early breast cancer. An overview of the randomized trials
Early Breast Cancer Trialists’ Collaborative Group
N Engl j med 333 (22), 1444-1455, 1995
9751995
Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial
T Arimidex
The lancet oncology 9 (1), 45-53, 2008
9532008
Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer
A Goldhirsch, WC Wood, RD Gelber, AS Coates, B Thurlimann, HJ Senn
Journal of clinical oncology 21 (17), 3357-3365, 2003
9312003
Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial
J Cuzick, I Sestak, M Baum, A Buzdar, A Howell, M Dowsett, JF Forbes
The lancet oncology 11 (12), 1135-1141, 2010
8422010
First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial.
J Cuzick, JF Forbes, I Sestak, S Cawthorn, H Hamed, K Holli, A Howell, ...
The Lancet 360, 817-824, 2002
7922002
Fulvestrant, formerly ICI 182,780, is as effective as anastrozole in postmenopausal women with advanced breast cancer progressing after prior endocrine treatment
A Howell, JFR Robertson, J Quaresma Albano, A Aschermannova, ...
Journal of Clinical Oncology 20 (16), 3396-3403, 2002
7902002
Dissociation between steroid receptor expression and cell proliferation in the human breast
RB Clarke, A Howell, CS Potten, E Anderson
Cancer research 57 (22), 4987-4991, 1997
7681997
Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early‐stage breast cancer: results of the ATAC …
ATAC (Arimidex, Tamoxifen Alone or in Combination) Trialists' Group
Cancer 98 (9), 1802-1810, 2003
7182003
The system can't perform the operation now. Try again later.
Articles 1–20